WHO WE ARE

Our expert leadership team is dedicated to developing world-class antimicrobials

With over 100 years of combined pharmaceutical industry experience, our leadership team has the expertise to efficiently bring bisphosphocins to market.

WHAT WE DO

We develop novel antimicrobial therapies for those who need them the most

A rapid and safe topical bactericide and fungicide has the potential to save millions of lives.

HOW WE DO IT

Bacterial and fungal infections are swiftly eliminated directly at the site of infection

Bisphosphocins rapidly kill bacteria and fungi by depolarizing microbial cell membranes, leading to cell death within minutes.

Addressable Patient Populations (US)

1800000

Chronic Diabetic Foot Ulcers (cDFU)

65000

Undisclosed Indication

450000

Catheter-related UTI

30000

Cystic Fibrosis (CF)

Stock News Now

Published on Feb 23, 2018
SNNLive spoke with Steve Parkinson, President and CEO of Lakewood-Amedex, Inc., a private company, at the BIO CEO & Investor Conference 2018 in New York City, NY.

IN THE NEWS